Access Acceleration Lead

Allegis Global Solutions; Greater London; Hybrid; GBP 120,000 - 180,000; Full time

Job summary

GSK is seeking an Access Acceleration Lead in London with global market access expertise to drive pricing and access strategies for the GIST asset. The role demands leadership across international markets, collaboration with Health Outcomes, Policy and Medical teams, and the ability to translate payer insights into strategic actions.

The successful candidate will manage external projects, develop value propositions, and influence stakeholders to maximize portfolio value while navigating diverse

Qualifications

• 5+ years experience in international pricing & market access strategy, with senior leadership experience.
• Strong knowledge of pricing policy across major markets (US, Japan, China), oncology focus preferred.
• Experience leading external project delivery and cross-functional collaboration.

Responsibilities

• Provide strategic advice and leadership on market access and pricing for GIST asset.
• Coordinate execution of external strategic access projects.
• Develop guidance on key strategic access issues with GI GMAx Director.
• Ensure a clear link between external projects and internal GMAx teams.
• Contribute to evidence generation plan to address payer questions.
• Support market access strategy development within brand plans.
• Identify gaps and opportunities for additional access activities.

Skills

International pricing

Market access strategy

External project delivery

Stakeholder influence

Cross-functional leadership

Communication

Job description

Job title: Access Acceleration Lead
Location: GSK HQ,London / Flexible (must be able to work UK time zone)

Duration: Approximately 12 months - from July 2026 to June 2027

Overview

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We are on an audacious journey to impact the health of 2.5 billion people over the next decade. Our R&D division is at the forefront of this mission, dedicated to the discovery and development of groundbreaking vaccines and medicines. We are transforming the landscape of medical research by integrating cutting-edge science and technology and harnessing the power of genetics and new data. By fostering a collaborative environment that unites the talents of our people, we are revolutionizing R&D to pre-empt and defeat diseases. Join us in our commitment to uniting science, technology, and talent to get ahead of disease together.

Role Overview

Global Market Access (GMAx) are key to maximizing the value of our products for patients, healthcare systems and for the company. The vision of the team is to be the industry leader in our ability to maximise patient access to life changing vaccines and medicines. To do this, we externally engage payers to fully recognise the value of our assets and internally act as a strategic leader to increase portfolio lifecycle value by delivering innovative solutions.

GSK will be expanding into gastro-intestinal stromal tumors (GIST) in the coming years, and wish to maximise the pricing & access environment for this important technology to transform the outcomes of people living with GIST. This involves a number of important external deliverables and strategic access projects, and the socialization of this strategy within the internal organisation.

Ready to shape the future of healthcare?

The GIST Access Acceleration Lead will leverage clinical understanding, expertise of Evidence Based Medicine, alongside deep global payer knowledge and competitive insights to shape the Pricing & Access strategy, evidence generation, and value communication tools & materials. We are looking for a passionate and experienced market access professional, to lead the execution of external projects including value proposition development and pricing research, and to act as an expert advisor on price & access strategy optimization activities.

Key Responsibilities

• Provide strategic advice and leadership to the GIST cross-functional team, globally with respect to market access and pricing, to develop innovative and competitive Payer Value Propositions and Pricing Strategies for this asset.
• Co-ordinate execution of external strategic access projects.
• Develop expert guidance on key strategic access issues, in collaboration with the GI GMAx Director.
• Provide ‘red thread’ of expert access strategy between the external projects and feeding into the GIST GMAx team.
• Input to the evidence generation plan to ensure it will address critical payer questions.
• Support the development of the market access strategy within the brand plan.
• Assess gaps and opportunities for additional Access activities to maximise probability of success for this asset.
• Collaborate with individuals across many functions, including Health Outcomes, Commercial, Policy and Medical teams, to ensure the access strategy is optimally developed and disseminated throughout the organisation.

MinimumQualifications

• 5+ years experience in international pricing & market access strategy, with most senior role at Director level.
• Good knowledge of all international markets, including US, Japan and China.
• Knowledge of pricing policy & regulations in key markets, ideally with Oncology-specific expertise.
• Experience in leading external project delivery.
• Experience in internal price and access strategy development.
• Excellent project management skills, prioritisation and problem-solving skills with high sense of responsibility and accountability.
• Strong communication and influencing skills, both internal and external, ideally including demonstrated ability to develop and mobilise key stakeholders to influence decisions, and remove barriers.
• Results-orientated with a sense of urgency and customer focus, resilient when overcoming obstacles.

Preferred Qualifications

• Experience in oncology, particularly GI tumours.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.

Inclusion at GSK

GSK is an EqualOpportunity/AffirmativeAction Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.

If you need any adjustments in the recruitment process, please get in touch with our Recruitment team([e-mail]) to further discuss this today.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency ReportingFor the Recordsite.